Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxil in Refractory Idiopathic Thrombocytopenic Purpura
NCT00107913Phase 2Unknown
- Sponsor
- Hematology and Oncology Specialists
- Start
- Sep 2001
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of pegylated liposomal doxorubicin in immune thrombocytopenia (ITP), sponsored by Hematology and Oncology Specialists. Status: unknown.
02
Drugs
pegylated liposomal doxorubicin
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT00107913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00107913.